Last 12 months
Inside the activity.
6 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 1 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 2 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 1 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2017 Filed Mar 3, 2017 23:22 UTC |
Zakrzewski Joseph SDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $17.75 | $0.00 |
DisclosureSEC source: 0001127602-17-010311 · form4.xml · derivative · entry 13 Zakrzewski Joseph S · CIK 0001331852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2022-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option is subject to a three-year vesting period with 50% of the total award vesting on April 30, 2013, 25% of the total award vesting on April 30, 2014 and 25% of the total award vesting on April 30, 2015, subject to continued service as a director or consultant. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 23:22 UTC |
Zakrzewski Joseph SDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $20.90 | $0.00 |
DisclosureSEC source: 0001127602-17-010311 · form4.xml · derivative · entry 12 Zakrzewski Joseph S · CIK 0001331852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2021-05-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option shall vest as to 100% of the total award on April 30, 2017, subject to continued service as a director or consultant. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 23:22 UTC |
Zakrzewski Joseph SDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $14.48 | $0.00 |
DisclosureSEC source: 0001127602-17-010311 · form4.xml · derivative · entry 11 Zakrzewski Joseph S · CIK 0001331852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2020-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option is subject to a three-year vesting period with 50% of the total award vesting on the first anniversary of the date of grant and 25% on each of the second and third anniversaries of the date of grant, subject to continued service as a director or consultant. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 23:22 UTC |
Zakrzewski Joseph SDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 18,480 | $0.00 Strike: $7.06 | $0.00 |
DisclosureSEC source: 0001127602-17-010311 · form4.xml · derivative · entry 10 Zakrzewski Joseph S · CIK 0001331852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,480 shares Expires 2019-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option is subject to a three-year vesting period with 50% of the total award vesting on the first anniversary of the date of grant and 25% on each of the second and third anniversaries of the date of grant, subject to continued service as a director or consultant. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 23:22 UTC |
Zakrzewski Joseph SDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,520 | $0.00 Strike: $18.75 | $0.00 |
DisclosureSEC source: 0001127602-17-010311 · form4.xml · derivative · entry 9 Zakrzewski Joseph S · CIK 0001331852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,520 shares Expires 2018-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is subject to a three-year vesting period with 50% of the total award vesting one year after the grant date, 25% of the total award vesting two years after the grant date and 25% of the total award vesting three years after the grant date, subject to continued service as a director or consultant. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 23:22 UTC |
Zakrzewski Joseph SDirector
|
SaleCommon Stock | 22,279 | $46.99 | $1,046,905.81 |
DisclosureSEC source: 0001127602-17-010311 · form4.xml · nonDerivative · entry 8 Zakrzewski Joseph S · CIK 0001331852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,849 F3 · price: The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $46.66 to $47.54. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. F1 · balance_after: Includes 3,810 restricted stock units granted on May 11, 2016, which vest on April 30, 2017; 1,000 restricted stock units granted on June 2, 2014, which vest on April 30, 2017; and 2,020 restricted stock units granted on May 13, 2015, which vest 50% of the total units on April 30, 2017 and 50% of the total units on April 30, 2018, subject to continued service as a director or consultant. Vested shares will be delivered to the reporting person as soon as practiable following a vesting date. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 23:22 UTC |
Zakrzewski Joseph SDirector
|
SaleCommon Stock | 13,721 | $46.31 | $635,464.79 |
DisclosureSEC source: 0001127602-17-010311 · form4.xml · nonDerivative · entry 7 Zakrzewski Joseph S · CIK 0001331852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,128 F2 · price: The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $45.65 to $46.645. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. F1 · balance_after: Includes 3,810 restricted stock units granted on May 11, 2016, which vest on April 30, 2017; 1,000 restricted stock units granted on June 2, 2014, which vest on April 30, 2017; and 2,020 restricted stock units granted on May 13, 2015, which vest 50% of the total units on April 30, 2017 and 50% of the total units on April 30, 2018, subject to continued service as a director or consultant. Vested shares will be delivered to the reporting person as soon as practiable following a vesting date. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 23:22 UTC |
Zakrzewski Joseph SDirector
|
SaleCommon Stock | 4,000 | $48.03 | $192,124.00 |
DisclosureSEC source: 0001127602-17-010311 · form4.xml · nonDerivative · entry 6 Zakrzewski Joseph S · CIK 0001331852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,849 F1 · balance_after: Includes 3,810 restricted stock units granted on May 11, 2016, which vest on April 30, 2017; 1,000 restricted stock units granted on June 2, 2014, which vest on April 30, 2017; and 2,020 restricted stock units granted on May 13, 2015, which vest 50% of the total units on April 30, 2017 and 50% of the total units on April 30, 2018, subject to continued service as a director or consultant. Vested shares will be delivered to the reporting person as soon as practiable following a vesting date. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 23:22 UTC |
Zakrzewski Joseph SDirector
|
Exercise / conversionCommon Stock | 4,000 | $17.75 | $71,000.00 |
DisclosureSEC source: 0001127602-17-010311 · form4.xml · nonDerivative · entry 5 Zakrzewski Joseph S · CIK 0001331852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,849 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 3,810 restricted stock units granted on May 11, 2016, which vest on April 30, 2017; 1,000 restricted stock units granted on June 2, 2014, which vest on April 30, 2017; and 2,020 restricted stock units granted on May 13, 2015, which vest 50% of the total units on April 30, 2017 and 50% of the total units on April 30, 2018, subject to continued service as a director or consultant. Vested shares will be delivered to the reporting person as soon as practiable following a vesting date. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 23:22 UTC |
Zakrzewski Joseph SDirector
|
Exercise / conversionCommon Stock | 4,000 | $20.90 | $83,600.00 |
DisclosureSEC source: 0001127602-17-010311 · form4.xml · nonDerivative · entry 4 Zakrzewski Joseph S · CIK 0001331852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,849 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 3,810 restricted stock units granted on May 11, 2016, which vest on April 30, 2017; 1,000 restricted stock units granted on June 2, 2014, which vest on April 30, 2017; and 2,020 restricted stock units granted on May 13, 2015, which vest 50% of the total units on April 30, 2017 and 50% of the total units on April 30, 2018, subject to continued service as a director or consultant. Vested shares will be delivered to the reporting person as soon as practiable following a vesting date. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 23:22 UTC |
Zakrzewski Joseph SDirector
|
Exercise / conversionCommon Stock | 4,000 | $14.48 | $57,920.00 |
DisclosureSEC source: 0001127602-17-010311 · form4.xml · nonDerivative · entry 3 Zakrzewski Joseph S · CIK 0001331852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,849 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 3,810 restricted stock units granted on May 11, 2016, which vest on April 30, 2017; 1,000 restricted stock units granted on June 2, 2014, which vest on April 30, 2017; and 2,020 restricted stock units granted on May 13, 2015, which vest 50% of the total units on April 30, 2017 and 50% of the total units on April 30, 2018, subject to continued service as a director or consultant. Vested shares will be delivered to the reporting person as soon as practiable following a vesting date. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 23:22 UTC |
Zakrzewski Joseph SDirector
|
Exercise / conversionCommon Stock | 18,480 | $7.06 | $130,468.80 |
DisclosureSEC source: 0001127602-17-010311 · form4.xml · nonDerivative · entry 2 Zakrzewski Joseph S · CIK 0001331852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,849 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 3,810 restricted stock units granted on May 11, 2016, which vest on April 30, 2017; 1,000 restricted stock units granted on June 2, 2014, which vest on April 30, 2017; and 2,020 restricted stock units granted on May 13, 2015, which vest 50% of the total units on April 30, 2017 and 50% of the total units on April 30, 2018, subject to continued service as a director or consultant. Vested shares will be delivered to the reporting person as soon as practiable following a vesting date. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 23:22 UTC |
Zakrzewski Joseph SDirector
|
Exercise / conversionCommon Stock | 9,520 | $18.75 | $178,500.00 |
DisclosureSEC source: 0001127602-17-010311 · form4.xml · nonDerivative · entry 1 Zakrzewski Joseph S · CIK 0001331852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,369 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 3,810 restricted stock units granted on May 11, 2016, which vest on April 30, 2017; 1,000 restricted stock units granted on June 2, 2014, which vest on April 30, 2017; and 2,020 restricted stock units granted on May 13, 2015, which vest 50% of the total units on April 30, 2017 and 50% of the total units on April 30, 2018, subject to continued service as a director or consultant. Vested shares will be delivered to the reporting person as soon as practiable following a vesting date. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 22:09 UTC |
Spears Michael PSVP, QA and RA
|
Tax withholdingCommon Stock | 1,186 | $45.96 | $54,508.56 |
DisclosureSEC source: 0001127602-17-008950 · form4.xml · nonDerivative · entry 1 Spears Michael P · CIK 0001667779 · SVP, QA and RA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,555 F1 · shares: This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations. F2 · balance_after: Includes 6,491 restricted stock units granted on February 22, 2017, which vest one-third of the total units on February 22, 2018, one-third of the total units on February 22, 2019, and one-third of the total units on February 22, 2020; 14,954 restricted stock units granted on July 27, 2015, which vest one-half of the total units on July 27, 2017 and one-half of the total units on July 27, 2018; and 6,836 restricted stock units granted on February 24, 2016, which vest one-half of the total units on February 24, 2018 and one-half of the total units on February 24, 2019, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 22:08 UTC |
Petrovic ShaceyPresident and COO
|
Tax withholdingCommon Stock | 2,732 | $45.96 | $125,562.72 |
DisclosureSEC source: 0001127602-17-008949 · form4.xml · nonDerivative · entry 1 Petrovic Shacey · CIK 0001631895 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,993 F1 · shares: This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations. F2 · balance_after: Includes 13,522 restricted stock units granted on February 22, 2017, which vest one-third of the total units on February 22, 2018, one-third of the total units on February 22, 2019, and one-third of the total units on February 22, 2020; 18,989 restricted stock units granted on February 9, 2015, which vest on February 9, 2018; 4,542 performance share units granted on April 1, 2015, which vest one-half of the total performance share units on April 1, 2017 and one-half of the total performance share units on April 1, 2018; and 14,240 restricted stock units granted on February 24, 2016, which vest one-half of the total units on February 24, 2018 and one-half of the total units on February 24, 2019, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date. F3 · balance_after: Includes an aggregate of 1,386 shares acquired under the Insulet Corporation 2007 Employee Stock Purchase Plan on the following dates: 712 shares on December 31, 2015 and 674 shares on June 30, 2016. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 18:36 UTC |
SULLIVAN PATRICK JDirector · CEO and Chairman of the Board
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 47,394 | $0.00 Strike: $46.22 | $0.00 |
DisclosureSEC source: 0001127602-17-008307 · form4.xml · derivative · entry 2 SULLIVAN PATRICK J · CIK 0001039138 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,394 Underlying: Common Stock · 47,394 shares Expires 2027-02-22 F4 · derivative.exercise_date: This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 18:36 UTC |
SULLIVAN PATRICK JDirector · CEO and Chairman of the Board
|
GrantCommon Stock | 18,033 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-008307 · form4.xml · nonDerivative · entry 1 SULLIVAN PATRICK J · CIK 0001039138 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,577 F1 · shares: The 18,033 restricted stock units vest one-third of the total units on February 22, 2018, and one-third of the total units on February 22, 2019, and one-third of the total units on February 22, 2020, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date. F2 · balance_after: Includes 29,100 restricted stock units granted on March 2, 2015, which vest one-half of the total units on March 2, 2017 and one-half of the total units on March 2, 2018; 30,432 performance share units granted on April 1, 2015, which vest one-half of the total performance share units on April 1, 2017 and one-half of the total performance share units on April 1, 2018; and 28,480 restricted stock units granted on February 24, 2016, which vest one-half of the total units on February 24, 2018 and one-half of the total units on February 24, 2019. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date. F3 · balance_after: Includes an aggregate of 1,451 shares acquired under the Insulet Corporation 2007 Employee Stock Purchase Plan on the following dates: 777 shares on December 31, 2015 and 674 shares acquired on June 30, 2016. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 23:46 UTC |
Abdel-Malek AimanSVP, Advanced Technology
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 11,372 | $0.00 Strike: $46.22 | $0.00 |
DisclosureSEC source: 0001127602-17-008330 · form4.xml · derivative · entry 2 Abdel-Malek Aiman · CIK 0001670040 · SVP, Advanced Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,372 Underlying: Common Stock · 11,372 shares Expires 2027-02-22 F4 · derivative.exercise_date: This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 23:46 UTC |
Abdel-Malek AimanSVP, Advanced Technology
|
GrantCommon Stock | 4,327 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-008330 · form4.xml · nonDerivative · entry 1 Abdel-Malek Aiman · CIK 0001670040 · SVP, Advanced Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,875 F1 · shares: The 4,327 restricted stock units vest one-third of the total units on February 22, 2018, one-third of the total units on February 22, 2019 and one-third of the total units on February 22, 2020, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date. F2 · balance_after: Includes 14,022 restricted stock units granted on March 28, 2016, which vest one-third of the total units on March 28, 2017, one-third of the total units on March 28, 2018 and one-third of the total units on March 28, 2019, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date. F3 · balance_after: Includes 474 shares acquired on November 30, 2016 under the Insulet Corporation 2007 Employee Stock Purchase Plan. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 23:42 UTC |
Colleran DavidSVP, Secretary and GC
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 11,372 | $0.00 Strike: $46.22 | $0.00 |
DisclosureSEC source: 0001127602-17-008320 · form4.xml · derivative · entry 2 Colleran David · CIK 0001646558 · SVP, Secretary and GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,372 Underlying: Common Stock · 11,372 shares Expires 2027-02-22 F4 · derivative.exercise_date: This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 23:42 UTC |
Colleran DavidSVP, Secretary and GC
|
GrantCommon Stock | 4,327 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-008320 · form4.xml · nonDerivative · entry 1 Colleran David · CIK 0001646558 · SVP, Secretary and GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,442 F1 · shares: The 4,327 restricted stock units vest one-third of the total units on February 22, 2018, and one-third of the total units on February 22, 2019, and one-third of the total units on February 22, 2020, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date. F2 · balance_after: Includes 14,418 restricted stock units granted on June 29, 2015, which vest one-half of the total units on June 29, 2017 and one-half of the total units on June 29, 2018; and 4,557 restricted stock units granted on February 24, 2016, which vest one-half of the total units on February 24, 2018 and one-half of the total units on February 24, 2019, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date. F3 · balance_after: Includes 94 shares acquired on November 30, 2016 under the Insulet Corporation 2007 Employee Stock Purchase Plan. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 23:44 UTC |
Alpuche CharlesEVP, Global Manufacturing
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 28,431 | $0.00 Strike: $46.22 | $0.00 |
DisclosureSEC source: 0001127602-17-008325 · form4.xml · derivative · entry 2 Alpuche Charles · CIK 0001665678 · EVP, Global Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,431 Underlying: Common Stock · 28,431 shares Expires 2027-02-22 F3 · derivative.exercise_date: This option is subject to a three-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 8 quarters, subject to continued employment. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 23:44 UTC |
Alpuche CharlesEVP, Global Manufacturing
|
GrantCommon Stock | 10,818 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-008325 · form4.xml · nonDerivative · entry 1 Alpuche Charles · CIK 0001665678 · EVP, Global Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,596 F1 · shares: The 10,818 restricted stock units vest one-third of the total units on February 22, 2018, and one-third of the total units on February 22, 2019, and one-third of the total units on February 22, 2020, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date. F2 · balance_after: Includes 10,681 restricted stock units granted on February 3, 2016, which vest one-half of the total units on February 3, 2018 and one-half of the total units on February 3, 2019, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 23:38 UTC |
Petrovic ShaceyPresident and COO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 35,538 | $0.00 Strike: $46.22 | $0.00 |
DisclosureSEC source: 0001127602-17-008311 · form4.xml · derivative · entry 2 Petrovic Shacey · CIK 0001631895 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,538 Underlying: Common Stock · 35,538 shares Expires 2027-02-22 F4 · derivative.exercise_date: This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 23:38 UTC |
Petrovic ShaceyPresident and COO
|
GrantCommon Stock | 13,522 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-008311 · form4.xml · nonDerivative · entry 1 Petrovic Shacey · CIK 0001631895 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,725 F1 · shares: The 13,522 restricted stock units vest one-third of the total units on February 22, 2018, and one-third of the total units on February 22, 2019, and one-third of the total units on February 22, 2020, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date. F2 · balance_after: Includes 18,989 restricted stock units granted on February 9, 2015, which vest on February 9, 2018; 4,542 performance share units granted on April 1, 2015, which vest one-half of the total performance share units on April 1, 2017 and one-half of the total performance share units on April 1, 2018; and 14,240 restricted stock units granted on February 24, 2016, which vest one-half of the total units on February 24, 2018 and one-half of the total units on February 24, 2019, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date. F3 · balance_after: Includes an aggregate of 1,386 shares acquired under the Insulet Corporation 2007 Employee Stock Purchase Plan on the following dates: 712 shares on December 31, 2015 and 674 shares on June 30, 2016. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 23:39 UTC |
Levitz Michael LSVP and CFO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 17,058 | $0.00 Strike: $46.22 | $0.00 |
DisclosureSEC source: 0001127602-17-008314 · form4.xml · derivative · entry 2 Levitz Michael L · CIK 0001468019 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,058 Underlying: Common Stock · 17,058 shares Expires 2027-02-22 F3 · derivative.exercise_date: This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 23:39 UTC |
Levitz Michael LSVP and CFO
|
GrantCommon Stock | 6,491 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-008314 · form4.xml · nonDerivative · entry 1 Levitz Michael L · CIK 0001468019 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,103 F1 · shares: The 6,491 restricted stock units vest one-third of the total units on February 22, 2018, and one-third of the total units on February 22, 2019, and one-third of the total units on February 22, 2020, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date. F2 · balance_after: Includes 28,686 restricted stock units granted on May 4, 2015, which vest one-half of the total units on May 4, 2017 and one-half of the total units on May 4, 2018; and 6,836 restricted stock units granted on February 24, 2016, which vest one-half of the total units on February 24, 2018 and one-half of the total units on February 24, 2019, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 23:37 UTC |
Spears Michael PSVP, QA and RA
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 17,058 | $0.00 Strike: $46.22 | $0.00 |
DisclosureSEC source: 0001127602-17-008308 · form4.xml · derivative · entry 2 Spears Michael P · CIK 0001667779 · SVP, QA and RA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,058 Underlying: Common Stock · 17,058 shares Expires 2027-02-22 F3 · derivative.exercise_date: This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 23:37 UTC |
Spears Michael PSVP, QA and RA
|
GrantCommon Stock | 6,491 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-008308 · form4.xml · nonDerivative · entry 1 Spears Michael P · CIK 0001667779 · SVP, QA and RA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,741 F1 · shares: The 6,491 restricted stock units vest one-third of the total units on February 22, 2018, and one-third of the total units on February 22, 2019, and one-third of the total units on February 22, 2020, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date. F2 · balance_after: Includes 14,954 restricted stock units granted on July 27, 2015, which vest one-half of the total units on July 27, 2017 and one-half of the total units on July 27, 2018; and 6,836 restricted stock units granted on February 24, 2016, which vest one-half of the total units on February 24, 2018 and one-half of the total units on February 24, 2019, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 23:35 UTC |
Thomas Bradley AEVP Human Resources
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 17,058 | $0.00 Strike: $46.22 | $0.00 |
DisclosureSEC source: 0001127602-17-008304 · form4.xml · derivative · entry 2 Thomas Bradley A · CIK 0001395641 · EVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,058 Underlying: Common Stock · 17,058 shares Expires 2027-02-22 F4 · derivative.exercise_date: This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 23:35 UTC |
Thomas Bradley AEVP Human Resources
|
GrantCommon Stock | 6,491 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-008304 · form4.xml · nonDerivative · entry 1 Thomas Bradley A · CIK 0001395641 · EVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,778 F1 · shares: The 6,491 restricted stock units vest one-third of the total units on February 22, 2018, and one-third of the total units on February 22, 2019, and one-third of the total units on February 22, 2020, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date. F2 · balance_after: Includes 6,061 restricted stock units granted on December 1, 2014, which vest on December 1, 2017; 8,203 restricted stock units granted on March 2, 2015, which vest one-half of the total units on March 2, 2017 and one-half of the total units on March 2, 2018; 4,542 performance share units granted on April 1, 2015, which vest one-half of the total performance share units vest on April 1, 2017 and one-half of the total performance share units vest on April 1, 2018; and 6,836 restricted stock units granted on February 24, 2016, which vest one-half of the total units on February 24, 2018 and one-half of the total units on February 24, 2019, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date. F3 · balance_after: Includes an aggregate of 1,264 shares purchased under the Insulet Corporation 2007 Employee Stock Purchase Plan on the following dates: 569 shares acquired on December 31, 2015; 568 shares acquired on June 30, 2016; and 127 shares acquired on November 30, 2016. Read SEC document |
| February 09, 2017 Filed Feb 10, 2017 21:50 UTC |
Petrovic ShaceyPresident and COO
|
Tax withholdingCommon Stock | 6,253 | $42.30 | $264,501.90 |
DisclosureSEC source: 0001127602-17-005036 · form4.xml · nonDerivative · entry 1 Petrovic Shacey · CIK 0001631895 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,203 F1 · shares: This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations. F2 · balance_after: Includes 18,989 restricted stock units granted on February 9, 2015, which vest on February 9, 2018; 4,542 performance share units granted on April 1, 2015, which vest one-half of the total performance share units on April 1, 2017 and one-half of the total performance share units on April 1, 2018; and 21,360 restricted stock units granted on February 24, 2016, which vest one-third of the total units on February 24, 2017, one-third of the total units on February 24, 2018 and one-third of the total units on February 24, 2019, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date. F3 · balance_after: Includes an aggregate of 1,386 shares acquired under the Insulet Corporation 2007 Employee Stock Purchase Plan on the following dates: 712 shares on December 31, 2015 and 674 shares on June 30, 2016. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 21:34 UTC |
Alpuche CharlesSVP, Global Manufacturing
|
Tax withholdingCommon Stock | 1,843 | $42.76 | $78,806.68 |
DisclosureSEC source: 0001127602-17-004351 · form4.xml · nonDerivative · entry 1 Alpuche Charles · CIK 0001665678 · SVP, Global Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,778 F1 · shares: This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations. F2 · balance_after: Includes 10,681 restricted stock units granted on February 3, 2016, which vest one-half of the total units on February 3, 2018 and one-half of the total units on February 3, 2019, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date. Read SEC document |
| December 09, 2016 Filed Dec 12, 2016 13:40 UTC |
Alpuche CharlesSVP, Global Manufacturing
|
PurchaseCommon Stock | 6,600 | $37.70 | $248,802.18 |
DisclosureSEC source: 0001127602-16-069618 · form4.xml · nonDerivative · entry 1 Alpuche Charles · CIK 0001665678 · SVP, Global Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,621 F1 · price: The price reported represents the weighted average purchase price of the shares purchased. The shares were purchased at varying prices in the range of $37.665 to $37.700. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares purchased at each separate price. F2 · balance_after: Includes 16,021 restricted stock units granted on February 3, 2016, which vest one-third of the total units on February 3, 2017, one-third of the total units on February 3, 2018 and one-third of the total units on February 3, 2019, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date. Read SEC document |
| December 02, 2016 Filed Dec 5, 2016 08:37 UTC |
SULLIVAN PATRICK JDirector · CEO and Chairman of the Board
|
PurchaseCommon Stock | 40,000 | $33.89 | $1,355,720.00 |
DisclosureSEC source: 0001127602-16-069057 · form4.xml · nonDerivative · entry 1 SULLIVAN PATRICK J · CIK 0001039138 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,544 F1 · price: The price reported represents the weighted average purchase price of the shares purchased. The shares were purchased at varying prices in the range of $33.089 to $34.000. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares purchased at each separate price. F2 · balance_after: Includes an aggregate of 1,451 shares acquired under the Insulet Corporation 2007 Employee Stock Purchase Plan on the following dates: 777 shares on December 31, 2015 and 674 shares acquired on June 30, 2016. F3 · balance_after: Includes 29,100 restricted stock units granted on March 2, 2015, which vest one-half of the total units on March 2, 2017 and one-half of the total units on March 2, 2018; 30,432 performance share units granted on April 1, 2015, which vest one-half of the total performance share units on April 1, 2017 and one-half of the total performance share units on April 1, 2018; and 42,720 restricted stock units granted on February 24, 2016, which vest one-third of the total units on February 24, 2017, one-third of the total units on February 24, 2018 and one-third of the total units on February 24, 2019. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date. Read SEC document |
| December 01, 2016 Filed Dec 5, 2016 13:36 UTC |
Thomas Bradley AEVP Human Resources
|
PurchaseCommon Stock | 3,100 | $32.45 | $100,595.00 |
DisclosureSEC source: 0001127602-16-069056 · form4.xml · nonDerivative · entry 1 Thomas Bradley A · CIK 0001395641 · EVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,983 F1 · price: The price reported represents the weighted average purchase price of the shares purchased. The shares were purchased at varying prices in the range of $32.45 to $32.47. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares purchased at each separate price. F2 · balance_after: Includes an aggregate of 1,137 shares purchased under the Insulet Corporation 2007 Employee Stock Purchase Plan on the following dates: 569 shares acquired on December 31, 2015 and 568 shares acquired on June 30, 2016. F3 · balance_after: Includes 6,061 restricted stock units granted on December 1, 2014, which vest on December 1, 2017; 8,203 restricted stock units granted on March 2, 2015, which vest one-half of the total units on March 2, 2017 and one-half of the total units on March 2, 2018; 4,542 performance share units granted on April 1, 2015, which vest one-half of the total performance share units vest on April 1, 2017 and one-half of the total performance share units vest on April 1, 2018; and 10,253 restricted stock units granted on February 24, 2016, which vest one-third of the total units on February 24, 2017, one-third of the total units on February 24, 2018 and one-third of the total units on February 24, 2019, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date. Read SEC document |
| October 12, 2016 Filed Oct 14, 2016 08:49 UTC |
SULLIVAN PATRICK JDirector · President & CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,075 | $0.00 Strike: $32.51 | $0.00 |
DisclosureSEC source: 0001127602-16-064786 · form4.xml · derivative · entry 2 SULLIVAN PATRICK J · CIK 0001039138 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,110 Underlying: Common Stock · 3,075 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment. F3 · derivative.underlying_shares: The transaction referenced in Tables I and II represents the exercise for cash by the reporting person of options to acquire 3,075 shares of the Company's common stock. All of the underlying shares of common stock issued upon exercise of the options have been retained by the reporting person and no sale of common stock occurred in connection with this transaction. Read SEC document |
| October 12, 2016 Filed Oct 14, 2016 08:49 UTC |
SULLIVAN PATRICK JDirector · President & CEO
|
Exercise / conversionCommon Stock | 3,075 | $32.51 | $99,968.25 |
DisclosureSEC source: 0001127602-16-064786 · form4.xml · nonDerivative · entry 1 SULLIVAN PATRICK J · CIK 0001039138 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,544 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 777 shares acquired on December 31, 2015 and 674 shares acquired on June 30, 2016 under the Insulet Corporation 2007 Employee Stock Purchase Plan. F2 · balance_after: Includes 29,100 restricted stock units granted on March 2, 2015, which vest one-half of the total units on March 2, 2017 and one-half of the total units on March 2, 2018; 30,432 performance share units granted on April 1, 2015, which vest one-half of the total performance share units on April 1, 2017 and one-half of the total performance share units on April 1, 2018; and 42,720 restricted stock units granted on February 24, 2016, which vest one-third of the total units on February 24, 2017, one-third of the total units on February 24, 2018 and one-third of the total units on February 24, 2019. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date. F3 · balance_after: The transaction referenced in Tables I and II represents the exercise for cash by the reporting person of options to acquire 3,075 shares of the Company's common stock. All of the underlying shares of common stock issued upon exercise of the options have been retained by the reporting person and no sale of common stock occurred in connection with this transaction. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.